Borstnar S, Palacova M, Łacko A, Timcheva C, Gal-Yam EN, Papazisis K, et al. Ribociclib plus letrozole in patients with hormone receptor‐positive, HER2‐negative advanced breast cancer with no prior endocrine therapy: subgroup analysis from the phase 3b CompLEEment‐1 trial: Subgroup analysis of the CompLEEment‐1 trial. Radiol Oncol [Internet]. 2022 Jul. 3 [cited 2026 Jul. 25];56(2):238-47. Available from: https://www.radioloncol.com/index.php/ro/article/view/3866